Jacobs Levy Equity Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Jacobs Levy Equity Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-32,862	Closed	-$363K	–	1079
2018 Q4	$363K	Buy	+32,862	New	+$457K	0.01%	783
2018 Q3	–	Sell	-71,479	Closed	-$1.46M	–	1109
2018 Q2	$1.46M	Sell	71,479 -151,903	-68%	-$3.26M	0.02%	575
2018 Q1	$4.05M	Sell	223,382 -8,480	-4%	-$141K	0.07%	318
2017 Q4	$3.23M	Buy	231,862 +42,943	+23%	+$580K	0.06%	358
2017 Q3	$3.5M	Buy	188,919 +20,590	+12%	+$344K	0.07%	312
2017 Q2	$2.85M	Buy	168,329 +79,298	+89%	+$1.21M	0.06%	354
2017 Q1	$1.19M	Buy	+89,031	New	+$1.39M	0.02%	526
2016 Q4	–	Sell	-30,500	Closed	-$357K	–	1095
2016 Q3	$357K	Sell	30,500 -37,500	-55%	-$441K	0.01%	774
2016 Q2	$734K	Hold	68,000	–	–	0.02%	667
2016 Q1	$628K	Buy	+68,000	New	+$732K	0.01%	681
2014 Q3	–	Sell	-52,890	Closed	-$639K	–	937
2014 Q2	$639K	Buy	+52,890	New	+$625K	0.01%	591

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Jacobs Levy Equity Management's MNTA Position: Q1 2019 in Review

Jacobs Levy Equity Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2019, closing a stake of 32,862 shares — an estimated $363K sold.

Jacobs Levy Equity Management first reported a position in MNTA in Q2 2014 and held it in 11 quarters. The position peaked at $4.05M in Q1 2018. 147 funds tracked by Wall St. Rank hold MNTA as of Q1 2019.

Jacobs Levy Equity Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
Jacobs Levy Equity Management sold 32,862 Momenta Pharmaceuticals, Inc. shares in Q1 2019, an estimated $363K.
Jacobs Levy Equity Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2014 and held it in 11 quarters.
Jacobs Levy Equity Management's Momenta Pharmaceuticals, Inc. position peaked at $4.05M in Q1 2018.
147 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2019.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.